title: AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses.
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.|Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: M A
authors.initials: MA
authors.lastname: Gillissen
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.|Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: G
authors.initials: G
authors.lastname: de Jong
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: S E
authors.initials: SE
authors.lastname: Levie
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: E
authors.initials: E
authors.lastname: Yasuda
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: A Q
authors.initials: AQ
authors.lastname: Bakker
authors.affiliation: Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: L M
authors.initials: LM
authors.lastname: Evers
authors.affiliation: Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: S T
authors.initials: ST
authors.lastname: Pals
authors.affiliation: Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: C
authors.initials: C
authors.lastname: Huisman
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: P M
authors.initials: PM
authors.lastname: van Helden
authors.affiliation: AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: H
authors.initials: H
authors.lastname: Spits
authors.affiliation: Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: M D
authors.initials: MD
authors.lastname: Hazenberg
mesh_terms: D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology / Q000502:physiology; D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000209:etiology; D020544:Graft vs Leukemia Effect / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000473:pathology* / Q000628:therapy; D008297:Male; D012008:Recurrence; D000069283:Rituximab / Q000009:adverse effects*; D014184:Transplantation, Homologous
chemical_list: D000069283:Rituximab